These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 36895543)
1. Quality of Life Assessment With European Organisation for Research and Treatment of Cancer Questionnaire (Head and Neck Module 43) and Its Clinicopathological Correlation Among Patients Treated for Oral Squamous Cell Carcinoma: An Exploratory Study. Ramalingam K; Krishnan M; Ramani P; Muthukrishnan A Cureus; 2023 Feb; 15(2):e34650. PubMed ID: 36895543 [TBL] [Abstract][Full Text] [Related]
2. Longitudinal Assessment of the Quality of Life in Oral Squamous Cell Carcinoma Patients. G P; Ramalingam K; Ramani P; Krishnan M Cureus; 2024 May; 16(5):e60596. PubMed ID: 38894763 [TBL] [Abstract][Full Text] [Related]
3. Light gradient boosting-based prediction of quality of life among oral cancer-treated patients. Ramalingam K; Yadalam PK; Ramani P; Krishna M; Hafedh S; Badnjević A; Cervino G; Minervini G BMC Oral Health; 2024 Mar; 24(1):349. PubMed ID: 38504227 [TBL] [Abstract][Full Text] [Related]
4. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929 [TBL] [Abstract][Full Text] [Related]
5. The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change. Singer S; Hammerlid E; Tomaszewska IM; Amdal CD; Herlofson BB; Santos M; Castro Silva J; Mehanna H; Fullerton A; Young T; Fernandez Gonzalez L; Inhestern J; Pinto M; Arraras JI; Yarom N; Bonomo P; Baumann I; Galalae R; Nicolatou-Galitis O; Kiyota N; Raber-Durlacher J; Salem D; Fabian A; Boehm A; Krejovic-Trivic S; Chie WC; Taylor KJ; Sherman AC; Licitra L; Machiels JP; Bjordal K; Eur J Cancer; 2024 Nov; 212():115062. PubMed ID: 39405647 [TBL] [Abstract][Full Text] [Related]
6. Treatment modality impact on quality of life for human papillomavirus-associated oropharynx cancer. Xu MJ; Plonowska KA; Gurman ZR; Humphrey AK; Ha PK; Wang SJ; El-Sayed IH; Heaton CM; George JR; Yom SS; Algazi AP; Ryan WR Laryngoscope; 2020 Feb; 130(2):E48-E56. PubMed ID: 30919470 [TBL] [Abstract][Full Text] [Related]
7. Factors associated with the quality of life for hospitalized patients with HPV-associated oropharyngeal squamous cell carcinoma. Yin X; Shan C; Wang J; Zhang H Oral Oncol; 2020 Apr; 103():104590. PubMed ID: 32050152 [TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
9. Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629. Hughes BGM; Mendoza RG; Basset-Seguin N; Vornicova O; Schachter J; Joshi A; Meyer N; Grange F; Piulats JM; Bauman JR; Chirovsky D; Zhang P; Gumuscu B; Swaby RF; Grob JJ Dermatol Ther (Heidelb); 2021 Oct; 11(5):1777-1790. PubMed ID: 34558040 [TBL] [Abstract][Full Text] [Related]
10. Head and Neck Cancer Patients' Quality of Life: Analysis of Three Instruments. Gomes EPAA; Aranha AMF; Borges AH; Volpato LER J Dent (Shiraz); 2020 Mar; 21(1):31-41. PubMed ID: 32158782 [TBL] [Abstract][Full Text] [Related]
11. The impact of radiotherapy on the quality of life in patients with early-stage clinical head and neck cancer. Milecki J; Żmijewska-Tomczak M; Osmola K; Wierzbicka M Otolaryngol Pol; 2021 May; 75(5):1-8. PubMed ID: 34552020 [TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma. Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996 [TBL] [Abstract][Full Text] [Related]
13. Prospective quality of life outcomes for human papillomavirus associated oropharynx cancer patients after surgery alone. Stephens EM; Plonowska-Hirschfeld K; Gulati A; Kansara S; Qualliotine J; Zelbolsky AL; van Zante A; Ha PK; Heaton CM; Ryan WR Am J Otolaryngol; 2023; 44(4):103915. PubMed ID: 37210888 [TBL] [Abstract][Full Text] [Related]
14. Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale. Singer S; Hammerlid E; Tomaszewska IM; Amdal CD; Bjordal K; Herlofson BB; Santos M; Silva JC; Mehanna H; Fullerton A; Brannan C; Gonzalez LF; Inhestern J; Pinto M; Arraras JI; Yarom N; Bonomo P; Baumann I; Galalae R; Nicolatou-Galitis O; Kiyota N; Raber-Durlacher J; Salem D; Fabian A; Boehm A; Krejovic-Trivic S; Chie WC; Taylor K; Simon C; Licitra L; Sherman AC; Qual Life Res; 2022 Mar; 31(3):841-853. PubMed ID: 34272632 [TBL] [Abstract][Full Text] [Related]
15. Exploring quality of life among head-and-neck cancer patients in Western India using European organization for research and treatment of cancer questionnaires. Parkar S; Sharma A; Shah M J Cancer Res Ther; 2022; 18(4):990-996. PubMed ID: 36149151 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the information given to patients undergoing head and neck cancer surgery using the EORTC QLQ-INFO25 questionnaire: A prospective multicentric study. Bozec A; Schultz P; Gal J; Chamorey E; Chateau Y; Dassonville O; Poissonnet G; Santini J; Peyrade F; Saada E; Guigay J; Benezery K; Leysalle A; Santini L; Giovanni A; Messaoudi L; Fakhry N Eur J Cancer; 2016 Nov; 67():73-82. PubMed ID: 27616438 [TBL] [Abstract][Full Text] [Related]
17. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients. Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients. Jerjes W; Upile T; Petrie A; Riskalla A; Hamdoon Z; Vourvachis M; Karavidas K; Jay A; Sandison A; Thomas GJ; Kalavrezos N; Hopper C Head Neck Oncol; 2010 Apr; 2():9. PubMed ID: 20406474 [TBL] [Abstract][Full Text] [Related]
19. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564 [TBL] [Abstract][Full Text] [Related]
20. Association of Site and Recurrence in Oral Squamous Cell Carcinoma Patients Visiting Private Hospital in Chennai: A Retrospective Study. Reichal P; Ramani P; Kizhakkoottu S Cureus; 2024 Jan; 16(1):e52774. PubMed ID: 38389605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]